[go: up one dir, main page]

CL2016001350A1 - Composiciones de ketoprofeno de accion prologanda. - Google Patents

Composiciones de ketoprofeno de accion prologanda.

Info

Publication number
CL2016001350A1
CL2016001350A1 CL2016001350A CL2016001350A CL2016001350A1 CL 2016001350 A1 CL2016001350 A1 CL 2016001350A1 CL 2016001350 A CL2016001350 A CL 2016001350A CL 2016001350 A CL2016001350 A CL 2016001350A CL 2016001350 A1 CL2016001350 A1 CL 2016001350A1
Authority
CL
Chile
Prior art keywords
action
proto
ketoprofen compositions
ketoprofen
compositions
Prior art date
Application number
CL2016001350A
Other languages
English (en)
Inventor
Ricahrd Andrew Ewin
Steven X Hu
Susan M Machkovech
Barton H Manning
Stephen Lee Secreast
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52347413&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2016001350(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of CL2016001350A1 publication Critical patent/CL2016001350A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSICIÓN VETERINARIA DE ACCIÓN PROLONGADA QUE COMPRENDE UN PROFÁRMACO DE ÉSTER DE KETOPROFENO, AL MENOS UN TRIGLICÉRIDO, UN CONSERVANTE Y OPCIONALMENTE AL MENOS UN EXCIPIENTE ADICIONAL; Y USO EN FORMA DE INYECTABLE PARA EL TRATAMIENTO DEL DOLOR, FIEBRE Y/O LA INFLAMACIÓN.
CL2016001350A 2013-12-16 2016-06-02 Composiciones de ketoprofeno de accion prologanda. CL2016001350A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361916462P 2013-12-16 2013-12-16

Publications (1)

Publication Number Publication Date
CL2016001350A1 true CL2016001350A1 (es) 2016-11-25

Family

ID=52347413

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016001350A CL2016001350A1 (es) 2013-12-16 2016-06-02 Composiciones de ketoprofeno de accion prologanda.

Country Status (16)

Country Link
US (1) US10632095B2 (es)
EP (1) EP3082762B1 (es)
JP (2) JP6306188B2 (es)
KR (1) KR101817028B1 (es)
CN (2) CN105848638A (es)
AU (1) AU2014366221C1 (es)
CA (1) CA2931858C (es)
CL (1) CL2016001350A1 (es)
DK (1) DK3082762T3 (es)
ES (1) ES2901706T3 (es)
MX (1) MX373714B (es)
NZ (1) NZ719783A (es)
PH (1) PH12016500910A1 (es)
PL (1) PL3082762T3 (es)
RU (1) RU2646829C1 (es)
WO (1) WO2015095045A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3082762T3 (da) * 2013-12-16 2021-12-06 Zoetis Services Llc Langtidsvirkende ketoprofensammensætninger
US9714403B2 (en) 2014-06-19 2017-07-25 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
CA3085488A1 (en) * 2017-12-11 2019-06-20 Meat & Livestock Australia Ltd Transdermal analgesic formulation
AU2019325407B2 (en) * 2018-08-24 2025-06-19 Centrexion Therapeutics Corporation Capsaicin sequential dosing method for treatment of knee joint pain
CN115252625B (zh) * 2022-08-11 2024-01-26 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一种环维黄杨星d在制备治疗非洲猪瘟的制剂中的应用
KR102798067B1 (ko) * 2023-11-07 2025-04-23 주식회사 삼양애니팜 아목시실린을 포함하는 반려동물용 지속형 항생제 및 이의 용도

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1709232A (en) * 1927-12-19 1929-04-16 James J Richardson Steering mechanism
FR1546478A (fr) 1967-01-27 1968-11-22 Rhone Poulenc Sa Nouveaux dérivés de l'acide benzoyl-3 phénylacétique et leur préparation
US4560785A (en) 1983-03-02 1985-12-24 Ss Pharmaceutical Co., Ltd. Phenylacetic ester derivatives and process for preparing the same
DE3324193A1 (de) 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
US6217911B1 (en) * 1995-05-22 2001-04-17 The United States Of America As Represented By The Secretary Of The Army sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
GB9118149D0 (en) * 1991-08-22 1991-10-09 Enzymatix Ltd Araylalkanoic acid resolution
CA2312898C (en) * 1997-12-03 2004-05-11 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated castor oil
US6291527B1 (en) * 1998-04-11 2001-09-18 Errekappa Euroterapici S.P.A. Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
US7666914B2 (en) * 2004-06-03 2010-02-23 Richlin David M Topical preparation and method for transdermal delivery and localization of therapeutic agents
CN1709232A (zh) * 2005-06-15 2005-12-21 沈阳药科大学 含有酮洛芬或酮洛芬酯的注射用脂质微球及其制备工艺
AU2007317629A1 (en) * 2006-10-27 2008-05-15 Noven Pharmaceuticals, Inc. Transdermal delivery of ketoprofen polar derivatives
CA2743551C (en) 2008-11-19 2017-08-15 Merial Limited Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol
FR2950533B1 (fr) 2009-09-28 2012-01-13 Maco Pharma Sa Formulation liquide, stable, prete a l'emploi de ketoprofene
CN102648897A (zh) * 2012-04-28 2012-08-29 东华大学 一种酮洛芬高分子前药聚合物微球及其制备方法
DK3082762T3 (da) * 2013-12-16 2021-12-06 Zoetis Services Llc Langtidsvirkende ketoprofensammensætninger

Also Published As

Publication number Publication date
WO2015095045A1 (en) 2015-06-25
AU2014366221B2 (en) 2019-06-13
EP3082762A1 (en) 2016-10-26
CA2931858A1 (en) 2015-06-25
CA2931858C (en) 2018-12-11
MX373714B (es) 2020-05-08
JP2016539997A (ja) 2016-12-22
ES2901706T3 (es) 2022-03-23
PL3082762T3 (pl) 2022-02-14
CN105848638A (zh) 2016-08-10
DK3082762T3 (da) 2021-12-06
AU2014366221C1 (en) 2019-10-03
JP6306188B2 (ja) 2018-04-04
EP3082762B1 (en) 2021-11-17
KR20160078491A (ko) 2016-07-04
BR112016012235A2 (pt) 2017-08-08
JP2018058880A (ja) 2018-04-12
RU2016121639A (ru) 2018-01-23
PH12016500910A1 (en) 2016-06-20
NZ719783A (en) 2017-01-27
US20160303065A1 (en) 2016-10-20
CN112843042A (zh) 2021-05-28
BR112016012235A8 (pt) 2018-01-30
RU2646829C1 (ru) 2018-03-07
MX2016007869A (es) 2016-10-07
KR101817028B1 (ko) 2018-01-09
US10632095B2 (en) 2020-04-28
AU2014366221A1 (en) 2016-05-26

Similar Documents

Publication Publication Date Title
CL2018003754A1 (es) Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo.
CL2016001350A1 (es) Composiciones de ketoprofeno de accion prologanda.
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
MX2015009104A (es) Composiciones en solución sólida y uso en el tratamiento de enfermedades cardiovasculares.
PE20151778A1 (es) Formulacion combinada de dos compuestos antivirales
CL2016001547A1 (es) Composiciones para el cuidado oral
CL2016000153A1 (es) Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b
CL2018000222A1 (es) Nueva combinación para el uso en el tratamiento del cáncer
CL2016001609A1 (es) Composiciones farmacéuticas que comprenden azd9291.
MX2016011810A (es) Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso.
PE20151759A1 (es) Imidazopiridazinas sustituidas
MX2016008429A (es) Derivado de piranocromenil fenol, y composicion farmaceutica para tratar un sindrome metabolico o enfermedad inflamatoria.
ECSP17038893A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
UY35651A (es) Pirazolpiridinas sustituidas
CR20150653A (es) Compuestos nuevos para el tratamiento del cáncer
AR095398A1 (es) Formulaciones con oxidación reducida
CL2016001130A1 (es) Composiciones sólidas de triglicéridos y usos de estas
MX2016011025A (es) Composiciones de grapiprant y metodos para usar las mismas.
MX2016014701A (es) (r)-pirlindol y sus sales farmaceuticamente aceptables para uso en medicina.
CL2015003211A1 (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio.
CO7170180A2 (es) Composición farmacéutica inyectable de dexketoprofeno y tramadol
AR130700A2 (es) Composiciones de grapiprant y métodos para su utilización
AR099681A1 (es) Composiciones de grapiprant y métodos para su utilización
CL2015002681A1 (es) Formulación de dosificación oral solida del inhibidor de hcv en estado amorfo
MX2017014893A (es) Composicion herbal para el tratamiento del dolor de espalda.